Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | STAT6 | P42226 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | APLNR | P35414 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13490845 | 1.00 | FFAR3 (0.65) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL503244 | 1.00 | FFAR3 (0.65) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL14012097 | 1.00 | FFAR3 (0.65) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL4442780 | 1.00 | FFAR3 (0.65) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL13315169 | 0.88 | FFAR3 (0.52) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL17893189 | 0.87 | FFAR3 (0.77) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL17893191 | 0.87 | FFAR3 (0.77) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL17893188 | 0.87 | FFAR3 (0.77) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL26409341 | 0.87 | FFAR3 (0.58) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL16983813 | 0.86 | FFAR3 (0.50) | FFAR3MAPK1TP53NFKB1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 536 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315248-A1 | NOVEL ANTIMICROBIAL COMPOSITIONS AND ARTICLES MADE THEREFROM | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-09-26 | — | — | US | claimed |
| EP-4271316-A1 | NOVEL ANTIMICROBIAL COMPOSITIONS AND ARTICLES MADE THEREFROM | 3M Innovative Properties Company (US) | 2023-11-08 | — | — | EP | claimed |
| CN-116635017-A | Novel antimicrobial compositions and articles made therefrom | 3M创新有限公司 | 2023-08-22 | — | — | CN | claimed |
| WO-2022144664-A1 | NOVEL ANTIMICROBIAL COMPOSITIONS AND ARTICLES MADE THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-07-07 | — | — | WO | claimed |
| CN-112126150-B | Recyclable POE vitrimer elastomer, foaming material, and preparation methods and applications thereof | 上海交通大学 | 2021-08-24 | — | — | CN | claimed |
| CN-112126150-A | Recyclable POE vitrimer elastomer, foaming material, and preparation methods and applications thereof | 上海交通大学 | 2020-12-25 | — | — | CN | claimed |
| US-9822217-B2 | Robust resin for solvent-free emulsification | XEROX CORPORATION (US) | 2017-11-21 | — | — | US | claimed |
| US-20130244151-A1 | Chemical Toner Including A Robust Resin For Solvent-Free Emulsification | XEROX CORPORATION | 2013-09-19 | — | — | US | claimed |
| US-20130245197-A1 | Robust Resin For Solvent-Free Emulsification | XEROX CORPORATION | 2013-09-19 | — | — | US | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20040220377-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | claimed |
| US-6329506-B1 | TEMPLATE-BOUND AMINO ACID SEQUENCE OF REPEATING PEPTIDE-PEPTOID TRIMERS; HAS CONFORMATION LIKE NATIVE COLLAGEN | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-12-11 | — | — | US | claimed |
| EP-0733216-B1 | A METHOD AND MATERIAL FOR THE DETECTION OF IONISING RADIATION | BRITISH NUCLEAR FUELS PLC (GB) | 2000-01-19 | — | — | EP | claimed |
| WO-1999066333-A1 | NEUTRAL ENHANCEMENT OF LANTHANIDES FOR TIME RESOLVED FLUORESCENCE | NEN LIFE SCIENCE PRODUCTS, INC. (US) | 1999-12-23 | — | — | WO | claimed |
| US-5856308-A | POLYPEPTIDES; WOUND HEALING AGENTS | HAEMACURE CORPORATION (CA) | 1999-01-05 | — | — | US | claimed |
| US-5723650-A | Cyclohexane tricarboxylic acid derivative and method for the preparation thereof | JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1998-03-03 | — | — | US | claimed |
| EP-0733216-A1 | A METHOD AND MATERIAL FOR THE DETECTION OF IONISING RADIATION | British Nuclear Fuels PLC (GB) | 1996-09-25 | — | — | EP | claimed |
| WO-1995016210-A1 | A METHOD AND MATERIAL FOR THE DETECTION OF IONISING RADIATION | BRITISH NUCLEAR FUELS PLC (GB) | 1995-06-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | FFAR3 3784/4885MAPK1 4104/4885TP53 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.